Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Contrast media injectors are devices used to inject contrast media agents into the bloodstream of patients, to enable visualization of various pathologies through X-ray, computed tomography, magnetic resonance, or other medical imaging devices. GlobalData uses proprietary data and analytics to provide a comprehensive report on the contrast media injectors market in Australia. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the contrast media injectors market in Australia was Bracco Imaging followed by Guerbet and Imaxeon.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Computed tomography (CT) injectors, magnetic resonance imaging (MRI) injectors and angiographic injectors have been included in this category. CT injectors are devices used in conjunction with CT systems to inject contrast media agents into the blood stream of patients. MRI injectors are devices used in conjunction with MRI systems to inject contrast media agents into the blood stream of patients. Angiographic Injectors are devices used during cardiac and vascular angiographic procedures to inject contrast media agents into the blood stream of patients.

The contrast media injectors market in Australia can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size contrast media injectors in Australia, buy the report here.

This content was updated on 1 March 2024

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.